Please login to the form below

Not currently logged in
Email:
Password:

Protelos

This page shows the latest Protelos news and features for those working in and with pharma, biotech and healthcare.

CHMP turns down Avastin for brain cancer

CHMP turns down Avastin for brain cancer

Both drugs were originally rejected earlier this year. It also reported that Servier had elected to withdraw its application to extend the indications of its osteoporosis therapy Protelos/Osser (strontium ranelate)

Latest news

  • EMA recommends heart risk restriction for Servier's Protelos EMA recommends heart risk restriction for Servier's Protelos

    EMA recommends heart risk restriction for Servier's Protelos. Use of osteoporosis drug likely to be further tightened up. ... That review brought restrictions that included a prohibition on the use of Protelos' in immobilised patients or patients with a

  • EMA restricts use of Servier’s Protelos and Osseor

    EMA restricts use of Servier’ s Protelos and Osseor. Osteoporosis drugs not to be used in patients with history of blood clots. ... Elderly patients were also shown to be more at risk of contracting VTE after use of Protelos and Osseor compared with

  • Process for NICE guidance re-evaluation

    Servier Laboratories, the licence holder of Protelos (strontium ranelate), which instigated the review, remains satisfied with Mr Holman's judgement that NICE acted with procedural unfairness, and therefore unlawfully, by not

  • High Court rules against NICE in osteoporosis case

    High Court rules against NICE in osteoporosis case. The High Court has ruled that NICE must look again at its decision not to fund the use of osteoporosis drug Protelos on ... The High Court has ruled that the National Institute for Health and Clinical

  • R&D News in brief

    Protelos shines in study. Servier's osteoporosis treatment, Protelos, is effective in reducing nonvertebral and vertebral fractures over five years, according to two new studies presented at the Sixth European Congress ... One trial of 1649

More from news
Approximately 1 fully matching, plus 9 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CACTUS

Founded in 2002, Cactus Communications is a fully integrated, global scholarly communications company with offices in Japan, South Korea, India,...

Latest intelligence

The Holy Grail of HCP Access
This is the data you need to gain access....
No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....

Infographics